Breakdown | ||||
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
75.93B | 77.77B | 71.98B | 62.27B | 55.25B | Gross Profit |
29.82B | 29.65B | 25.85B | 22.74B | 19.89B | EBIT |
9.56B | 9.36B | 7.34B | 6.42B | 4.39B | EBITDA |
15.34B | 15.27B | 13.48B | 11.64B | 6.58B | Net Income Common Stockholders |
8.30B | 7.95B | 3.72B | 6.16B | 4.03B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
10.22B | 11.13B | 12.99B | 12.05B | 16.72B | Total Assets |
147.81B | 145.07B | 151.50B | 139.61B | 123.90B | Total Debt |
47.92B | 46.60B | 50.64B | 48.70B | 44.57B | Net Debt |
38.76B | 36.51B | 40.17B | 39.16B | 30.53B | Total Liabilities |
91.58B | 92.01B | 96.70B | 90.33B | 84.07B | Stockholders Equity |
51.26B | 47.79B | 48.90B | 44.37B | 36.39B |
Cash Flow | Free Cash Flow | |||
9.58B | 10.02B | 8.16B | 8.27B | 7.31B | Operating Cash Flow |
11.66B | 12.24B | 10.24B | 10.00B | 8.86B | Investing Cash Flow |
-3.28B | -3.18B | -2.49B | -15.49B | -5.18B | Financing Cash Flow |
-8.88B | -8.73B | -7.50B | 785.00M | 3.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €163.65B | 17.30 | 14.18% | 2.48% | -1.13% | 8.98% | |
73 Outperform | €159.15B | 14.10 | 18.65% | 2.81% | 3.39% | -36.50% | |
68 Neutral | €24.70B | 4.81 | 16.28% | 3.05% | -15.16% | 254.42% | |
66 Neutral | €305.20B | 53.21 | 12.91% | 0.84% | 10.51% | 203.70% | |
65 Neutral | €14.21B | 21.86 | 4.37% | 2.46% | 0.10% | 27.83% | |
64 Neutral | $4.24B | 11.64 | 5.23% | 249.83% | 4.07% | -10.54% | |
56 Neutral | €39.62B | 53.61 | 2.02% | 8.00% | -2.04% | 2258.97% |